Back to Journals » OncoTargets and Therapy

OncoTargets and Therapy

ISSN: 1178-6930


Editor-in-Chief: Professor Gaetano Romano

OncoTargets and Therapy is an international, peer-reviewed journal focusing on the molecular diagnosis of and targeted molecular or precision therapy for all types of cancer. This journal explores the evidence behind new and existing therapies to aid their informed acceptance by clinicians and treatment adherence by patients.

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).

Latest articles:

- 5 records -

M2-Type Macrophages and Cancer-Associated Fibroblasts Combine to Promote Colorectal Cancer Liver Metastases

Feng Y, Qiao S, Chen J, Wen X, Chen Y, Song X, Xu J, Qiao X, Yang J, Zhang S, Feng Y, Gao Y

OncoTargets and Therapy 2024, 17:243-260

Published Date: 26 March 2024

Progerin Inhibits the Proliferation and Migration of Melanoma Cells by Regulating the Expression of Paxillin

Liu W, Huang X, Luo W, Liu X, Chen W

OncoTargets and Therapy 2024, 17:227-242

Published Date: 22 March 2024

Development and Validation of a Machine Learning-Based Model Used for Predicting Hepatocellular Carcinoma Risk in Patients with Hepatitis B-Related Cirrhosis: A Retrospective Study

Hou Y, Yan J, Shi K, Liu X, Gao F, Wu T, Meng P, Zhang M, Jiang Y, Wang X

OncoTargets and Therapy 2024, 17:215-226

Published Date: 23 March 2024


Read more articles